Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help

Immunology

Volumn 132, Issue 4, 2011, Pages 549-558

  Ontiveros, Fernando ^a   Wilson, Elizabeth B ^a   Livingstone, Alexandra M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CD4 helper T cells (Th cells, Th0, Th1, Th2, Th3, Th17); CD8 cytotoxic T cells; Dendritic cells; Inflammation; Natural killer cells (NK cells)

Indexed keywords

ALPHA INTERFERON; HY ANTIGEN; INTERFERON RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; LYMPH NODE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, LY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; H-Y ANTIGEN; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PEPTIDE FRAGMENTS; RECEPTOR, INTERFERON ALPHA-BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952533673     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03400.x     Document Type: Article

References (55)

1. + T-cell response. Nat Rev Immunol 2004; 4:595-602.
2. + T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4:1009-15.
3. Sun JC, Bevan MJ. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol 2004; 172:3385-9.
4. + T cell responses in vivo. J Immunol 2003; 171:6339-43.
5. + T cells generated depends on the nature of the initial nonspecific stimulation. Eur J Immunol 2002; 32:1541-9.
6. + T cell to a fully functional tumor killer cell. Cancer Res 2002; 62:6438-41.
7. + T lymphocytes. Nature 2003; 421:852-6.
8. + T cells after acute infection. Nat Immunol 2004; 5:927-33.
9. + T cell memory. Science 2002; 297:2060-3.
10. + T cells. J Exp Med 1996; 184:863-71.
11. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337-9.
12. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339-42.
13. von Herrath MG, Yokoyama M, Dockter J, Oldstone MB, Whitton JL. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996; 70:1072-9.
14. Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science 2009; 324:1569-72.
15. Fröhlich A, Kisielow J, Schmitz I et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009; 324:1576-80.
16. Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009; 324:1572-6.
17. Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003; 171:2366-73.
18. + T-cell-independent pathway for antitumor CTL induction. Blood 2005; 106:338-44.
19. Mocikat R, Braumuller H, Gumy A et al. Natural killer cells activated by MHC class I (low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003; 19:561-9.
20. Krebs P, Barnes MJ, Lampe K, Whitley K, Bahjat KS, Beutler B, Janssen E, Hoebe K. NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses. Blood 2009; 113:6593-602.
21. + T cells. Cell 1992; 71:1205-14.
22. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264:1918-21.
23. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54:777-85.
24. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990; 171:377-87.
25. MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003; 198:615-21.
26. + T cell help. J Exp Med 1997; 186:65-70.
27. Millrain M, Chandler P, Dazzi F, Scott D, Simpson E, Dyson PJ. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J Immunol 2001; 167:3756-64.
28. Oehen S, Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 1998; 161:5338-46.
29. Guerder S, Matzinger P. A fail-safe mechanism for maintaining self-tolerance. J Exp Med 1992; 176:553-64.
30. Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004; 20:539-50.
31. Livingstone AM, Kuhn M. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens. Eur J Immunol 1999; 29:2826-34.
32. + T cell memory in the absence of cross-priming by host APC. Eur J Immunol 2002; 32:281-90.
33. + T cell responses. J Immunol 2008; 181:7445-8.
34. + T-helper and a T-killer cell. Nature 1998; 393:474-8.
35. + T cells. J Immunol 2005; 174:710-7.
36. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5:1249-55.
37. Winzler C, Rovere P, Rescigno M et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185:317-28.
38. Sanchez PJ, McWilliams JA, Haluszczak C, Yagita H, Kedl RM. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J Immunol 2007; 178:1564-72.
39. + T cells. J Immunol 2007; 178:778-87.
40. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005; 174:4465-9.
41. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202:637-50.
42. Le Bon A, Montoya M, Edwards MJ et al. A role for the transcription factor RelB in IFN-α production and in IFN-α-stimulated cross-priming. Eur J Immunol 2006; 36:2085-93.
43. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, Vucikuja S. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol 2006; 176:4525-9.
44. + T cell numbers, effector function, and antitumor activity. J Immunol 2009; 182:7398-407.
45. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 2006; 177:1746-54.
46. Janssen E, Tabeta K, Barnes MJ et al. Efficient T cell activation via a Toll-Interleukin 1 receptor-independent pathway. Immunity 2006; 24:787-99.
47. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161:1947-53.
48. + T cell expansion with variable dependence on type I IFN. J Exp Med 2004; 199:775-84.
49. + T cells in vivo by IL-15. Immunity 1998; 8:591-9.
50. Mattei F, Schiavoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001; 167:1179-87.
51. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 2005; 11:748-56.
52. Joshi NS, Kaech SM. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol 2008; 180:1309-15.
53. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 2009; 182:2786-94.
54. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434:88-93.
55. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 2006; 18:676-82.